G Medical Innovations Holdings Ltd
GMVDF
$0.0002
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 6.47% | -35.53% | -84.79% | -49.77% | -15.32% |
| Total Depreciation and Amortization | -11.01% | 2.50% | 19.57% | 6.21% | -3.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23,165.52% | -270.12% | -150.85% | -125.46% | -99.47% |
| Change in Net Operating Assets | -66.98% | -148.58% | -202.74% | -125.33% | 52.47% |
| Cash from Operations | -60.77% | -205.44% | -706.72% | -380.32% | -147.34% |
| Capital Expenditure | -285.64% | -424.94% | -680.33% | -258.24% | -8.48% |
| Sale of Property, Plant, and Equipment | -50.00% | -75.00% | -100.00% | 0.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.49% | -3.20% | 1,626.67% | 4,104.55% | 798.08% |
| Cash from Investing | -12,388.24% | -1,325.62% | -613.26% | -164.26% | 96.26% |
| Total Debt Issued | 171.45% | 204.29% | 384.84% | 352.55% | 327.45% |
| Total Debt Repaid | -217.14% | -285.23% | -366.43% | -46.99% | 60.04% |
| Issuance of Common Stock | -59.44% | -70.35% | -79.16% | -34.09% | 49.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 3,845.95% | 3,845.95% | 3,845.95% | -- |
| Cash from Financing | -13.92% | -6.09% | 2.15% | 56.15% | 220.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.70% | -194.71% | -192.47% | -146.63% | 1,970.50% |